| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 11/18/2009 | CN101579425A Oral pharmaceutical preparation |
| 11/18/2009 | CN101579421A Chinese herbal medicinal health capsule for assisting in preventing and treating alcoholic liver injury, and preparation method thereof |
| 11/18/2009 | CN101579415A Medicinal dripping pill for treating biliary calculus |
| 11/18/2009 | CN101579414A Medicinal composition for treating biliary calculus |
| 11/18/2009 | CN101579409A Traditional Chinese medicine composition for treating white diarrhea and preparation method thereof |
| 11/18/2009 | CN101579408A Chinese medicine powder for preventing and treating white diarrhea for baby pigs and preparation method thereof |
| 11/18/2009 | CN101579405A Traditional Chinese medicine for curing constipation and preparation method thereof |
| 11/18/2009 | CN101579396A Euphorbia humifusa dispersing tablet and preparation process thereof |
| 11/18/2009 | CN101579395A Traditional Chinese medicine for treating kidney weakness |
| 11/18/2009 | CN101579392A Honeysuckle-leaf effective-part medicinal composition and preparation method thereof |
| 11/18/2009 | CN101579385A Medicinal dripping pill for treating anorexia nervosa |
| 11/18/2009 | CN101579383A Method for preparing white ginseng |
| 11/18/2009 | CN101579375A Extract of bupleurum, preparation method and application thereof |
| 11/18/2009 | CN101579344A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 11/18/2009 | CN101579343A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 11/18/2009 | CN101579341A Novel use of pantoprazole sodium in treatment of cholecystitis |
| 11/18/2009 | CN101579340A Composite medicine preparation for treating gastro-enteritis and gastric ulcer |
| 11/18/2009 | CN101579324A Method for preparing omeprazole enteric fast-release tablet |
| 11/18/2009 | CN101579119A Nutritional food with function of relaxing bowel and preparation method thereof |
| 11/18/2009 | CN100561229C A cytocapacity test |
| 11/18/2009 | CN100560123C Extractive of traditional Chinese medicine and capsule for treating fatty liver, and its preparing method |
| 11/18/2009 | CN100560118C Preparation of Chinese traditional medicine for treating recurrent ulcer of oral cavity |
| 11/18/2009 | CN100560107C Traditional Chinese medicine composition, its preparation and quality controlling means |
| 11/18/2009 | CN100560098C Gastropathy treating medicine and its preparation |
| 11/18/2009 | CN100560092C Externally used traditional Chinese medicine for treating hepatitis B and hepatic ascites |
| 11/18/2009 | CN100560073C N4-acylcytosine nucleosides for treatment of viral infections |
| 11/18/2009 | CN100560068C Levogyration sulpiride injection preparation method |
| 11/18/2009 | CN100560066C Preparation method of a compound glutamine medicine composition |
| 11/18/2009 | CN100560063C Pill preparation of 'Shen Bao', its preparation method and quality control method |
| 11/18/2009 | CN100559937C Method for hatching fowl eggs |
| 11/17/2009 | US7619001 Utilization of dialkylfumarates |
| 11/17/2009 | US7618791 Detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells |
| 11/17/2009 | US7618643 Growth factor delivery system for the healing of wounds and the prevention of inflammation and disease |
| 11/17/2009 | US7618638 Matrix metalloprotease inhibitor |
| 11/17/2009 | US7618629 Manipulation of cytokine levels using CD83 gene products |
| 11/17/2009 | CA2588495C The utility of uridine nucleosides in the treatment of cachexia |
| 11/17/2009 | CA2522051C Diamine derivative, production process therefor and antioxidant |
| 11/17/2009 | CA2470519C Heteroaryl substituted pyrrole modulators of metabotropic glutamate receptor-5 |
| 11/17/2009 | CA2432181C Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists |
| 11/17/2009 | CA2411368C Therapeutic combinations of fatty acids |
| 11/17/2009 | CA2399299C Compounds with chelation affinity and selectivity for first transition series elements and their use |
| 11/17/2009 | CA2396958C Pet food composition for treating gastric helicobacter-like organisms (ghlos) in pets |
| 11/17/2009 | CA2393809C Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 11/17/2009 | CA2321198C 2-arylethyl-(piperidin-4-ylmethyl)amine derivatives as muscarinic receptor antagonists |
| 11/17/2009 | CA2259583C Azolo triazines and pyrimidines |
| 11/12/2009 | WO2009137334A2 Method for treating neurodegenerative dysfunction |
| 11/12/2009 | WO2009137086A1 Oral administration of peripherally-acting opioid antagonists |
| 11/12/2009 | WO2009136629A1 Prophylactic/therapeutic agent for lifestyle-related diseases |
| 11/12/2009 | WO2009136625A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 11/12/2009 | WO2009136611A1 Glutathione production enhancer, prophylactic/therapeutic agent for diseases associated with lack of glutathione, and food, beverage and feed |
| 11/12/2009 | WO2009135867A1 Sialic acid to support salivation |
| 11/12/2009 | WO2009135842A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 11/12/2009 | WO2009135581A2 Novel nip thiazole derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase-1 |
| 11/12/2009 | WO2009135352A1 A plum tree extract, a method for preparing the plum tree extract and use thereof |
| 11/12/2009 | WO2009108828A3 Solubility-enhanced forms of aprepitant and pharmaceutical compositions thereof |
| 11/12/2009 | WO2009105234A3 Methods and compositions for the treatment of disorders associated with defects of the cystic fibrosis transmembrane conductance regulator gene or protein |
| 11/12/2009 | WO2009073067A3 Compositions and methods for ameliorating hyperlipidemia |
| 11/12/2009 | WO2008133344A3 Piperidine derivative and use thereof |
| 11/12/2009 | US20090281170 Polynucleotide therapy |
| 11/12/2009 | US20090281164 RNA INTERFERENCE MEDIATED INHIBITION OF RESPIRATORY SYNCYTIAL VIRUS (RSV) EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 11/12/2009 | US20090281128 Caspase inhibitors and uses thereof |
| 11/12/2009 | US20090281116 Pyrrole derivatives, preparation thereof and therapeutic use thereof |
| 11/12/2009 | US20090280191 Preventive remedial therapeutic agent for phosphorus impairment, oral agent for adsorbing phosphate ion contained in food, beverage and chemical, and process for producing them |
| 11/12/2009 | US20090280183 Multiparticulate form of administration, comprising nucleic acid-containing mucoadhesive active ingredients, and method for producing said form of administration |
| 11/12/2009 | US20090280173 Multilayer Omeprazole Tablets |
| 11/12/2009 | US20090280146 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria |
| 11/12/2009 | US20090280117 Methods for the treatment or prevention of immune disorders using anti-cd40 antibodies |
| 11/12/2009 | US20090280098 Composition for beverage or food |
| 11/12/2009 | US20090280089 Inhibition of the liver tropism of adenoviral vectors |
| 11/12/2009 | US20090280086 Methods and compositions for treating hepatitis c virus |
| 11/12/2009 | CA2723744A1 Sialic acid to support salivation |
| 11/12/2009 | CA2723688A1 Method for treating neurodegenerative dysfunction |
| 11/12/2009 | CA2723685A1 Oral administration of peripherally-acting opioid antagonists |
| 11/12/2009 | CA2721815A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 11/12/2009 | CA2721303A1 Azetidines and cyclobutanes as histamine h3 receptor antagonists |
| 11/11/2009 | EP2116541A1 Proline derivatives and their use as dipeptidyl peptidase IV inhibitors |
| 11/11/2009 | EP2116264A1 Preparation for transnasal application |
| 11/11/2009 | EP2116245A2 EGFR kinase inhibitor combinations for treating respiratory and gastrointestinal disorders |
| 11/11/2009 | EP2116139A1 Sialic acid to support brain health in the elderly |
| 11/11/2009 | EP2114970A1 Tricyclic compounds and their use as glucocorticoid receptor modulators |
| 11/11/2009 | EP2114918A1 Process for solvent removal from omeprazole salts |
| 11/11/2009 | EP2114917A2 Pyrrole compounds |
| 11/11/2009 | EP2114888A1 Tricyclic compounds and their use as glucocorticoid receptor modulators |
| 11/11/2009 | EP2114530A2 Treatment of faecal incontinence |
| 11/11/2009 | EP1960401B1 Tricyclic amide derivatives useful for treating obesity |
| 11/11/2009 | EP1960396B1 Carbamate compounds as 5-ht4 receptor agonists |
| 11/11/2009 | EP1884240B1 Pharmaceutical for prevention or treatment of bone metabolic disease |
| 11/11/2009 | EP1575964B1 N-(benzyl)aminoalkyl carboxylate, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 11/11/2009 | EP1401451B1 Quinazoline derivatives which promote the release of parathyroid hormone |
| 11/11/2009 | EP1397351B1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 11/11/2009 | EP1372634B1 Use of fumaric acid amides |
| 11/11/2009 | EP1315812B1 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 11/11/2009 | EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils |
| 11/11/2009 | EP1191943B1 Anti-allergic peptides |
| 11/11/2009 | CN101575372A Analogue of human keratinocyte growth factor-1 and preparation method and application thereof |
| 11/11/2009 | CN101575335A Dehydrogenated silibinin substituted by meta-chlorobenzene formoxyl, preparation method and pharmaceutical applications thereof |
| 11/11/2009 | CN101574527A Liver-targeting intelligent nano-micelle prodrug system and preparation thereof |
| 11/11/2009 | CN101574520A Methods of administering anti-TNF alpha antibodies |
| 11/11/2009 | CN101574513A Stomachic hericium erinaceum polysaccharide health-care capsule |
| 11/11/2009 | CN101574509A Agerasia preparation |